Drug Interactions Flashcards
polypharmacy may lead to what type of changes?
- pharmacokinetic
2. pharmacodynamic
what are some pharmacokinetic changes due to polypharmacy?
- altered rates of absorption
- altered protein binding (distribution)
- different rates of metabolism
- different rates of excretion
what are some pharmacodynamic changes due to polypharmacy?
- competition at receptors
2. non-pharmacologic interactions
which drugs are highly protein bound in plasma?
- aspirin
- barbiturates
- phenytoin
- sulfonomides
- valproic acid
- warfarin
T/F: it is the free drug (unbound from protein) that has its therapeutic effect
true
what may happen if polypharmacy causes altered protein binding (distribution)?
can be a toxic buildup of the drug in the blood
what may cause altered protein binding (distrubution) of polypharmacy?
- protein binding sites become saturated
- if pt has hypoalbuminemia (e.g. liver damage)
- a drug is displaced from protein binding by another drug
if drug A inhibitis the P450 enzyme that metabolizes drug B, then what will happen?
there will be an increased level of drug B in blood (potential toxicity)
if drug A induces the P450 enzyme that metabolized drug B, then what will happen?
then there will be a decreased level of drug B in the blood
classification of chemical interactions
- additive
- synergistic
- potentiation
- antagonism
additive interactions
when combined effects of 2 drugs equal the sum of the effect of each agent given alone
synergistic interactions
when the combined effects of 2 drugs are greater than t he sum of the effect of each agent given alone
potentiation interactions
creation of a toxic effect from one drug (that is not normally toxic) due to presence of another drug
T/F: in potentiation interactions, the second drug is usually affected
false, 2nd drug is usually NOT affected
antagonism interaction
combined effect of 2 drugs is less than the individual agents given alone (the opposite of synergism)